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Abstract
Introduction and Objectives—The frequency of copper deficiency and clinical manifestations
following roux-en-y gastric bypass (RYGB) surgery is not yet clear. Objectives were to determine
the prevalence and incidence of copper deficiency in patients who have undergone RYGB.
Design and Methods—We sought to determine the number of RYGB patients undergoing
medical and nutritional follow-up visits at the Emory Bariatric Center who experienced copper
deficiency and associated hematological and neurological complaints (n = 136). Separately, in
patients followed longitudinally before and during 6 and 24 months following RYGB surgery, we
obtained measures of copper status (n = 16). Systemic blood cell counts and measures of copper,
zinc and ceruloplasmin were determined using standardized assays in reference laboratories
including atomic absorption spectrometry and immunoassays.
Results—Thirteen patients were identified to have copper deficiency suggesting a prevalence of
copper deficiency of 9.6%, and the majority of these had concomitant complications including
anemia, leukopenia and various neuro-muscular abnormalities. In the longitudinal study, plasma
copper concentrations and ceruloplasmin activity decreased over 6 and 24 months following
surgery, respectively (P<0.05), but plasma zinc concentrations did not change. A simultaneous
decrease in white blood cells was observed (P<0.05). The incidence of copper deficiency in these
subjects was determined to be 18.8%.
Conclusions—The prevalence and incidence of copper deficiency following RYGB surgery
was determined to be 9.6% and 18.8%, respectively, with many patients experiencing mild-to-
moderate symptoms. Given that copper deficiency can lead to serious and irreversible
complications if untreated, frequent monitoring of the copper status of RYGB patients is
warranted.
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Introduction
Copper is an essential nutrient for humans and is a cofactor for several metalloenzymes that
participate in critical body functions, including the mitochondrial respiratory chain
(cytochrome c oxidase), elastin synthesis (lysyl oxidase), neurotransmitter synthesis
(dopamine β-monooxygenase), protection from oxidative stress (Cu/Zn superoxide
dismutase), iron absorption in enterocytes (hephaestin) and pigmentation (tyrosinase). The
function of these and other cuproenzymes has been studied for many decades.1 Newer
research suggests that the copper proteome in eukaryotes is much more expansive, about 1%
of all proteins.2 Also, new physiological roles for copper are emerging in the literature; for
example, in cell signaling,3 oncogenesis4 and in immune function.5
Copper deficiency is thought to be rare in the general US population because copper is
found in commonly consumed foods, such as shellfish, whole grains, beans, nuts, dark leafy
green vegetables and organ meats. The median dietary intake of copper in the US diet, is 1.0
to 1.6 mg day−1, which is usually sufficient to meet nutrient requirements (recommended
dietary allowance = 0.9 mg Cuday−1 for adults).6 For this reason, copper is sometimes not
added to multi-vitamin/multimineral supplements and is rarely measured by clinicians.
Although not common, copper absorption can be impaired in some circumstances; copper
uptake is limited by high dietary Zn2+,7 and particularly following partial or complete
gastric resection because bioavailability of copper requires an acidic gastric environment.8
Also, because copper absorption primarily occurs in the duodenum9 patients whom have had
intestinal resection bypass (for example, malabsorptive bariatric surgery)10,11 are at risk.
These facts strongly suggest that patients who have undergone gastrectomy and
gastrointestinal bariatric surgery are particularly susceptible to copper deficiency.
Bariatric surgery is an uniquely effective treatment for individuals with severe obesity, and
is associated with alleviation of major comorbidities, and reduced risk of mortality.12,13
Given its effectiveness, bariatric surgery is gaining popularity as the number of procedures
performed in the United States each year has increased, and at least 1.2 million individuals
are currently affected.14,15 Currently in the United States, the roux-en-y gastric bypass
(RYGB) is the most popular surgery, and considered to be the gold-standard bariatric
procedure.16 The RYGB surgery procedure surgically alters the gastrointestinal tract by
dramatically reducing stomach capacity, thereby restricting food intake and by re-routing
ingested food to bypass the duodenum and the proximal jejunum, the main sites of copper
absorption.17
Along with others, we have documented severe copper deficiency following gastric bypass
surgery in several case-reports18–22 and in a cross-sectional study.23 Features of copper
deficiency in individuals with documented depletion included hematologic abnormalities
(anemia with or without leukopenia, neutropenia and/or thrombocytopenia) and various
neuropathies (unsteady gait, muscle weakness and fatigue, extremity numbness and/or
painful extremity paresthesias). In many cases, these symptoms initially were believed to be
attributable to iron or vitamin B12 deficiency, but when patients did not respond to
conventional treatments, further investigation revealed severely low copper status.18,20,22
Following copper supplementation, hematologic abnormalities are rapidly resolved, but
improvement in myeloneuropathic signs and symptoms can be variable, suggesting that
long-term deterioration may be irreversible.18,24,25 These studies suggest that copper
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deficiency following gastric bypass surgery may be under-diagnosed, which may lead to
serious morbidity.
There is a lack of information about the prevalence and incidence of copper deficiency
following gastric bypass surgery. In a cross-sectional analysis of 78 patients who had
undergone gastric bypass surgery, the prevalence of copper deficiency was recently reported
to be 15.4%.23 In this study, we sought to confirm this finding in a larger population of
bariatric surgery patients. A second and more important objective was to determine the true
incidence of copper deficiency following gastric bypass surgery by longitudinally measuring
changes in indicators of copper status before and during 24 months following RYGB.
Patients and methods
The study objectives were: (1) to determine the prevalence of copper deficiency following
RYGB; and (2) to determine the incidence of copper deficiency. These objectives were
approached using two different patient populations as described below in study 1 and study
2.
Patients
Study 1—Objective 1 was assessed via a retrospective chart review of patients in the
Emory Bariatric Center clinic population. Patients were eligible if they had undergone
RYGB as well as postoperative follow-up medical evaluation and nutritional screening in
the Emory Bariatric Center between March 2007 and March 2009. The RYGB surgical
procedure has been described26 and the length of roux limb (100 or 150 cm) was recorded.
During this period, 136 patients were screened. This included the analysis of copper,
ceruloplasmin, zinc, and vitamin B12 as well as routine hematological studies. A detailed
medical history and physical examination was also conducted on every patient. The Emory
University Institutional Review Board approved the study (IRB 912-2003).
Study 2—Objective 2 was assessed in a prospective cohort study of 16 severely obese
female patients who had been followed up for 24 months to assess the longer-term impact of
RYGB on cardiometabolic and nutritional outcomes.27,28 Subjects were evaluated at
baseline (before surgery) and again at 6 and 24 months post surgery. Exclusion criteria for
this study were: (1) male gender; (2) age <18 years or >65 years; and (3) preoperative body
mass index of <35 kg m−2. All patients were prescribed a multivitamin/multimineral
regimen following surgery and patients were counseled by a registered dietician about these
recommendations at each study visit. Dietary and supplement intake, using 3-day food
records, was collected at the 24-month visit only (n = 10), and were analyzed using Food
Processor SQL (ESHA Research, Salem, OR, USA). The Emory University Institutional
Review Board approved the study and all patients signed informed consent before
enrollment (IRB 333-2002).
Metabolic measures
Plasma samples were obtained at baseline (before surgery), 6 and 24 months following
surgery and stored at −80 °C. For study 1, serum copper and zinc were commercially
measured by ARUP Laboratories, Salt Lake City, UT, USA using inductively coupled
plasma/mass spectrometry. The limit of sensitivity and coefficient of variation were stated
by the company as 0.157 µmol l−1 and 7% for copper and 0.08 µmol l−1 and 5% for zinc,
respectively. Hematological measures, including hemoglobin, hematocrit and automated cell
counts were determined using standard methods at the Emory Medical Laboratory, a fully
certified reference laboratory.29 In a subsample of patients, serum vitamin B12 and ferritin
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were measured at the Emory Medical Laboratory using a standard chemiluminescent
immunoassay.
For study 2, ceruloplasmin activity and immunoreactive protein in plasma were determined
by established protocols.30 The human ceruloplasmin enzyme assay uses o-dianisidine as
substrate under standard conditions developed earlier.31 Plasma copper and zinc were
determined by flame atomic absorption spectroscopy after dilution with metal-free water as
described previously.32 Standards were prepared in 5% glycerol to mimic the viscosity of
diluted plasma.
Statistical analysis
The statistical software STATISTICA (StatSoft Inc., Tulsa, OK, USA) was used for study
analysis. For both study 1 and study 2, descriptive statistics were assessed using parametric
test and expressed as mean ± s.e. of the mean. Prevalence of copper deficiency was
determined in study 1 and was defined as the number of cases of copper deficiency during
the period from March 2007 to March 2009; the denominator was 136 subjects. Incidence of
copper deficiency was defined as the new development of copper deficiency during the 24-
month period following surgery, in 16 subjects who had normal copper status at baseline;
this was determined in study 2. Differences between population frequencies were assessed
using χ2 analysis. For study 2, changes over time from baseline to 24 months following
surgery were analyzed using repeated-measures analysis of variance. Relationships between
plasma copper concentrations and secondary variables, including plasma ceruloplasmin
activity were examined using Pearson correlations. In a subsample of five patients within
study 2, who experienced the greatest baseline to post-surgery change in ceruloplasmin
activity, changes in variables were assessed using paired t-tests. The significance level for
the study was set at P<0.05.
Results
In the cross-sectional study, study 1, 136 eligible patients were assessed. The population was
89% female, 70% Caucasian and 28% African American. At the time of the chart review,
(March 2009), subjects were 42.9 ± 0.8 years of age and were 33 ± 2 months post RYGB
surgery. Out of these 136 eligible patients, 13 were found to be deficient in copper, defined
as a value of <11 µmol l−1 in males and 12.6 µmol l−1 in females, a prevalence of 9.6%
(Figure 1). Of the copper-deficient patients, all were female, six were African American and
seven were Caucasian, and the average age was 44.2 ± 2.3 years (Table 1). Copper
deficiency was observed equally in patients who were within the first year of surgery, or
who were within years 1 to 3, or within years 3 to 5 post surgery. There were no significant
differences between copper-deficient and non-deficient groups in age, gender or race/
ethnicity.
Demographic and clinical data of study 1 patients with low copper status is given in Table 1.
Of interest is that development of clinical symptoms occurred in a third of patients within
the first 5 years of surgery, which indicates that copper deficiency can occur within a
relatively short time frame. Most (9 out of 13) individuals with low copper status also
exhibited sequelae that could be secondary to copper deficiency including anemia (46%) and
leukopenia (15%), as well as fatigue (38%), and various neuropathies (38%). Chart review
revealed reported symptoms as not ambulatory, unsteady gait, muscle weakness and pain,
extremity numbness, and painful extremity paresthesias. Anemia, the most prevalent of all
the abnormalities noted, can result from copper deficiency as well as deficiencies in other
nutrients including iron and vitamin B12. Iron stores, assessed by serum ferritin values, were
below normal in three out of seven patients for whom values could be obtained. In contrast,
none of the eight patients with recorded cobalamin values were in the deficient range.
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In the longitudinal study 2, 16 patients were assessed from baseline to 24 months following
RYGB surgery. The mean age was 33.1 ± 2.0 years. In all, 4 women were self-described as
African American in descent, 11 were Caucasian and 1 was Hispanic. Body mass index
decreased from 49.0 ± 0.9 kg m−2 at baseline to 35.7 ± 1.2 kg m−2 at 6 months and 31.6 ±
1.6 kg m−2 at 24 months following surgery; other changes in adiposity have been published
in greater detail elsewhere.28
Changes in plasma concentrations of copper, zinc and ceruloplasmin activity during the 24
months following RYGB surgery are presented in Table 2. Compared with baseline
concentrations, plasma copper decreased (effect of time, P = 0.019), by 10.8% at 6 months
compared with baseline values (P = 0.03) and 10.1% at 24 months (P = 0.04) following
surgery. There was no change in plasma zinc concentrations following surgery. Plasma
ceruloplasmin activity also decreased following surgery (effect of time, P = 0.019), and at 24
months, activity had decreased by 18.6% compared with baseline values (P = 0.016) (Figure
2). Also at 24 months following surgery, plasma ceruloplasmin activity below the normal
cutoff of 62 units l−1(ref. 31) was found in three subjects who each had normal activity at
baseline. This corresponds to an incidence of copper deficiency following gastric bypass
surgery of 18.8%.
To determine clinical manifestations of decreasing copper status following RYGB, we
assessed corresponding changes in plasma hemoglobin and total white blood cells (Table 2).
Compared with baseline values, a dramatic decrease in concentrations of white blood cells
was observed as early as 6 months (P = 0.006) and also at 24 months (P = 0.000) following
surgery (effect of time, P = 0.0001).29 At 24 months, anemia was found in 50% of subjects.
We did not collect information on neurological complaints for subjects in the longitudinal
study.
Data regarding iron and vitamin B12 status were pooled from those subjects in studies 1 and
2 who were copper deficient and who had normal copper status (Table 3). Subjects who had
copper deficiency had lower blood hemoglobin (118.1 ± 3.6 versus 129.6 ± 1.1 g l−1) and
ferritin (84.4 ± 21.8 versus 213.3 ± 42.3 pmol l−1) concentrations compared with those with
normal copper status (P<0.05). However, blood concentrations of vitamin B12 were similar
between copper-deficient and copper-sufficient groups (447.0 ± 55.2 and 497.5 ± 35.1 pmol
l−1, respectively).
In order to determine whether copper measures at 24 months following surgery were altered
by the length of the malabsorptive roux limb, we compared plasma concentrations of copper
and ceruloplasmin activity in patients who had obtained a 100 cm versus those with a 150
cm roux-limb. In both groups, comparable plasma copper concentrations (22.2 ± 2.3 and
22.6 ± 2.8 µmol l−1, respectively) and ceruloplasmin activity (91.3 ± 16.2 and 98.9 ± 15.3
units l−1, respectively) were found.
Dietary intake of copper and zinc are associated with copper status. Copper and zinc intake
from food or supplements was obtained from ten patients (in study 2) at 24 months
following surgery and was found to be 1.09 ± 0.3 and 8.8 ± 2.4 mg day−1, respectively.
There were no correlations between dietary intake of copper and zinc and circulatory
concentrations at the 24-month timepoint. There was also no difference in copper intake
between copper-deficient and copper-sufficient subjects (1.59 ± 0.85 and 0.92 ± 0.29 mg
day−1, respectively).
Plasma copper concentrations and plasma ceruloplasmin activity values were strongly
correlated at each timepoint (baseline, 0.93; 6 months, 0.97; and 24 months, 0.91, P<0.000
for each). This suggests that circulatory ceruloplasmin activity responds to decreases in
plasma copper concentrations, thus we wanted to determine whether corresponding
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decreases in plasma content of ceruloplasmin could also be observed. Using western blotting
analysis, immunoreactive ceruloplasmin was detected in plasma of a subsample of five
patients (in study 2) who were observed to have the greatest change in ceruloplasmin
activity following surgery (decreased to 44% of baseline, P = 0.004); transferrin protein was
used as a loading control (Figure 3). In this subsample of patients, plasma copper
concentrations following surgery were decreased to 70% of baseline (P = 0.09), but zinc
concentrations were unchanged. Plasma ceruloplasmin concentrations following surgery
were decreased to 82% of baseline (P = 0.004) but transferrin concentrations were
unchanged.
Discussion
In this study, we demonstrate the impact of RYGB surgery on copper nutritional status using
a cross-sectional and longitudinal analysis of two separate patient populations. In a cross-
sectional study of a clinic population of RYGB patients, we found the prevalence of copper
deficiency to be 9.6%. We show for the first time, in roux-en-y patients who were followed
longitudinally for 24 months following surgery, that the incidence of copper deficiency is
18.8%. A majority of the copper-deficient subjects in both populations exhibited symptoms
that may have been secondary to copper deficiency, including anemia, leukopenia and
various neuropathies.
Copper deficiency following gastric surgeries including RYGB has been described, but
much of the literature comprises case-reports.18,21,33,34 In a recent retrospective review of
78 patients who had gastric bypass surgery (average 1.3-year post surgery), Ernst et al.23
reported a deficiency of 15.4%. Other retrospective reviews of copper deficiency in patients
who had underwent RYGB35 or the more malabsorptive bariatric procedures, jejunoileal
bypass10,11 or biliopancreatic diversion procedure36 have been published but there was
insufficient data to determine prevalence statistics. This study reviewed a larger series of
patients (n = 136) and found the prevalence of copper deficiency to be 9.6%. Our laboratory
used a lower cutoff than the former study (12.6 µg dl−1 versus 13.3 µmol l−1); given that the
cutoffs from one laboratory to the next are not transferrable,37 both prevalence rates are
within range. Interestingly, there did not seem to be a time period following surgery during
which patients were more likely to develop low copper. Although copper deficiency has
been reported in many patients who have undergone RYGB several years earlier,18,35 we
observed copper deficiency in patients within the first year following surgery, and this has
been reported elsewhere in a case report.21
Micronutrient depletion following bariatric surgery has been demonstrated38 but only by a
few longitudinal studies.28,36,39 The novelty of this study is that it describes the impact of
RYGB by measuring systemic copper concentrations before and during the 2 years after
surgery. Although the study population is small, we found an incidence of 19% copper
deficiency, as defined by ceruloplasmin activity.31 Although the cutoff defining deficiency
may be arbitrary,37 a steady decrease in both copper concentrations and ceruloplasmin
activity was observed (in the case of copper as early as 6 months following surgery). This
finding suggests that for individuals, copper status may worsen following RYGB. The same
phenomenon was not observed for zinc, which remained stable following surgery. The
discrepancy between the incidence and prevalence rates of copper deficiency observed in
this study is not clear. It is possible that copper deficiency may be transient in some
individuals and may resolve over the long-term because of increased dietary intake40 or
improved copper absorption because of gut adaptation.41 Larger prospective studies with
longer follow-up are needed to assess these issues.
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In this study, below normal blood concentrations of copper were associated with symptoms
of copper deficiency including hematological and neurological abnormalities. Copper-
deficient patients had concomitant anemia and lower blood hemoglobin and ferritin
concentrations but normal vitamin B12 concentrations. Recognition of anemia in humans
with copper deficiency has been known since the nineteenth century, but the mechanism of a
copper–iron interaction is not clear.42 Pernicious anemia, which occurs with vitamin B12
deficiency, is not as likely to occur because most patients adhere to periodic cobalamin
administration following RYGB.43 Other than hematological abnormalities, many patients
experienced putative copper deficiency-related complaints including fatigue, poor wound
healing, hair loss, paresthesia, carpal tunnel syndrome, and muscle and joint pain. Although
the effects of copper supplementation were not determined in this study, several other
studies have shown that with copper repletion many of the hematological abnormalities are
rapidly resolved,10 and improvement in myeloneuropathy is seen, although long-term
deterioration may be irreversible.18,24 An additional concern is the effect of copper
deficiency in the growing fetus.44 These findings taken together with this study highlight the
short- and long-term risks of symptomatic copper deficiency following RYGB.
The relatively high frequency of symptomatic copper malnutrition following RYGB
suggests that greater screening of patients for copper depletion serially would be prudent. A
lack of sensitive and specific biomarkers for assessing copper status makes it difficult to
monitor and treat patients at risk for deficiency.45 Blood copper levels are tightly regulated,
thus normal copper levels may falsely indicate adequate copper status.46 As has been
described, we demonstrated strong correlations between concentrations of plasma copper
and ceruloplasmin activity in this study. Moreover, in a preliminary analysis, plasma
ceruloplasmin content (by western blotting assay) decreased in parallel with plasma copper
and further testing should determine whether blotting for plasma ceruloplasmin is a simple
and low cost way to assess copper status.
An explanation for the negative impact of RYGB surgery on copper absorption, is the
exclusion of most of the stomach and duodenum, which are the principal areas of copper
digestion and uptake.8,9 Another possibility is that surgery promotes food restriction and
many patients experience food intolerances.40 Although some patients do not adhere to a
daily regimen of micronutrient supplementation post surgery,47 our assessment of dietary
copper intake at 24 months following surgery showed that it was adequate with regard to
daily recommendations for the general population. It will be important for future studies to
determine whether current dietary copper recommendations meet the nutritional
requirements of RYGB patients, in whom copper malabsorption is likely due to exclusion of
the duodenum and proximal jejunum after the bypass.
The limitations of this paper is that the chart review in study 1, and dietary and neurological
information aspects of the longitudinal analysis were obtained retrospectively, thus some
variables had missing data for some subjects. It is therefore possible that the number of
patients dealing with neurological complaints is underestimated. The number of patients in
the longitudinal study was small, and although it was adequately powered for changes in
copper concentrations, it may not have been powered to detect changes in secondary
outcomes including hemoglobin concentrations. Also the majority of study participants were
female, and although this is reflective of the bariatric surgery population generally, there
may be important gender differences in copper metabolism following RYGB that were not
uncovered.9
Despite the limitations of this study, our findings suggest that copper status is impaired
within months following RYGB and this has mild-to-moderate clinical manifestations in
many patients. We found that the prevalence of copper deficiency in a RYGB clinic
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population was 9.6%, which is similar to that reported earlier. We also found an incidence of
18.8% in copper deficiency following RYGB surgery, which could lead to serious
complications if left undetected and untreated. This study demonstrates that copper
malnutrition following RYGB is not uncommon. Greater efforts for screening of this patient
population are warranted since the number of patients undergoing this bariatric procedure is
increasing.
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Serum copper in a RYGB clinic population. Serum copper concentrations were determined
in patients (n = 136) who had undergone RYGB surgery at the Emory Bariatric Center and
had visited the clinic for medical and nutritional follow-up during March 2007 and March
2009. Each patient number and their copper measurement(s) is (are) plotted; some patients
had multiple clinic visits. Closed squares are values in the normal range, (12.6–24.3 µmol
l−1)29, 13 samples are below the normal cutoff and considered deficient (open squares).
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Changes in plasma ceruloplasmin activity during 24 months following RYGB surgery.
Ceruloplasmin activity was serially determined in study 2 subjects (n = 16) before
(baseline), and 6 and 24 months following RYGB surgery and each individual data point is
plotted (open squares). The mean and standard error of the mean for each timepoint is
represented by closed squares. At 24 months following surgery, 3 ceruloplasmin activity
values dropped below the normal cutoff.31 An asterisk (*) depicts values significantly
different from baseline, P = 0.016.
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Changes in ceruloplasmin activity and concentration following RYGB surgery. Changes in
ceruloplasmin (Cp) density following surgery, relative to baseline levels, detected by
western immunoblots in a subgroup of study 2 subjects who exhibited the greatest decrease
in ceruloplasmin activity (mean = 44% of baseline) is shown (n = 5). Transferrin (Tf)
density, used as a loading control, was not altered post surgery. Plasma copper (Cu) and zinc
(Zn) concentrations were determined by flame atomic absorption spectrometry. An asterisk
(*) depicts significant reductions compared with baseline measures, P<0.05.
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Table 1





   Female 13
Ethnicity
   African American 6
   Caucasian 7
Months post surgery
   0 to 11.9 months 5 (38%)
   12 to 35.9 months 5 (38%)
   36 to 60 months 3 (23%)
Serum copper (µg dl−1) 59.2 ± 4.6
Hematological symptoms
   Anemia 6 (46%)
   Leukopenia 2 (15%)
Fatigue 5 (38%)
Neurological symptoms 5 (38%)
The demographic and symptom data of 13 patients in study 1 with deficient copper status is presented. Anemia was defined as hemoglobin <114 g
l−1; leukopenia was defined as white blood cell count <3.6 × 109 l−1. When present, fatigue and neurological symptoms including weakness, not
ambulatory, paraesthesia, carpal tunnel syndrome, tingling, joint pain and myalgias were noted in the patient’s charts.
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Table 2
Longitudinal changes in copper status and hematology following roux-en-y gastric bypass surgery
Baseline 6 Month 24 Months
Copper (µmol l−1) 24.6 ± 1.6 22.0 ± 1.8* 22.2 ± 1.8*
Zinc (µmol l−1) 13.0 ± 0.5 11.8 ± 0.5 13.1 ± 0.6
Ceruloplasmin activity (units l−1) 111.7 ± 9.4 107.5 ± 13.3 91.0 ± 11.3*
Hemoglobin (g l−1) 125.3 ± 3.5 122.4 ± 2.9 112.9 ± 2.9
White blood cells (× 109 l−1) 8.84 ± 0.87 6.46 ± 0.52* 5.83 ± 0.35*
Copper and zinc concentrations and ceruloplasmin activity, as well as hemoglobin and white blood cells were measured in plasma samples
obtained from 16 patients who underwent roux-en-y gastric bypass surgery as described in Patients and methods for study 2. An asterisk (*) depicts
significant decrease compared with the measure at baseline, by post hoc analysis, P < 0.05.
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Table 3
Assessment of iron status in copper-deficient and -sufficient subjects
Copper deficient Copper sufficient
Hemoglobin (g l−1) 118.1 ± 3.6* 129.6 ± 1.1
Ferritin (pmol l−1) 84.4 ± 21.8* 213.3 ± 42.3
Vitamin B12 (pmol l−1) 447.0 ± 55.2 497.5 ± 35.1
Blood concentrations of hemoglobin, ferritin and vitamin B12 were obtained from patients undergoing roux-en-y gastric patients in study 1
(retrospective chart review) and study 2 (longitudinal study) who had normal copper status (n = 110) and those who developed copper deficiency (n
= 25). An asterisk (*) depicts values that were significantly decreased compared with the value in copper-sufficient subjects, P < 0.05.
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